OraSure Technologies announced Tuesday its OraQuick HIV self-test, which can produce results in 20 minutes, received a ...

People in Canada have a new, less invasive way to test for HIV at home, following Health Canada's approval of an oral ...

OraSure Technologies, Inc. (“OraSure”) (NASDAQ: OSUR), a leader in point-of-need and home diagnostic tests and sample management solutions, today announced its OraQuick™ HIV Self-Test has received a ...

The OraQuick HIV home test breaks barriers and could expand HIV testing. Dec. 18, 2012 — -- Dan Nainan had never heard of a home test for HIV until a prospective girlfriend insisted that he take ...

“Expanding access to HIV testing options is a critical component in the global effort to end the HIV epidemic,” said Carrie Eglinton Manner, President and CEO of OraSure, in a news release. “Early ...

BETHLEHEM, Pa., Jan. 07, 2025 (GLOBE NEWSWIRE) -- In a release issued under the same headline on Tuesday, January 7th by OraSure Technologies, Inc. (NASDAQ: OSUR), please note that the first sentence ...

NICE has developed a medtech innovation briefing (MIB) on the OraQuick HCV point-of-care test for rapid detection of hepatitis C virus antibodies. The OraQuick HCV is a rapid, point-of-care diagnostic ...

Expansion of the OraQuick® HIV Self-Test to individuals aged 14 and older increases access to vital HIV testing for adolescents, addressing a significant public health need. The approval aligns with ...

This briefing describes the regulated use of the technology for the indication specified, in the setting described, and with any other specific equipment referred to. It is the responsibility of ...